At the University of Maryland, Baltimore, researchers are using a practical method, bacterial enzymatic combinatorial chemistry (BECC), to generate functionally diverse molecules that can potentially be used as adjuvants.

A study published this week in mBio demonstrates that a novel technique can be used to build better vaccines for infectious diseases. The study shows that a practical method, bacterial enzymatic combinatorial chemistry (BECC), can be used to generate functionally diverse molecules that can potentially be used as adjuvants

Clostridium difficile infection is an important cause of intestinal disease, primarily affecting hospitalized patients exposed to antibiotics. Participants discuss this disturbing trend as well as the potential role of animals and the food supply and the status of current vaccine development efforts.